Femasys (FEMY) Other Non-Current Liabilities (2020 - 2026)
Femasys (FEMY) posted Other Non-Current Liabilities of $1.3 million for Q1 2026, down 75.98% on a QoQ basis from $5.2 million in Q4 2025, and down 32.26% year-over-year from $1.9 million in Q1 2025.
Femasys (FEMY) Other Non-Current Liabilities (2020 - 2026) Analysis & Trends
Femasys' Other Non-Current Liabilities history runs 7 years deep, the most recent figure standing at $1.3 million for Q1 2026.
- Quarterly Other Non-Current Liabilities fell 32.26% year-over-year to $1.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 million (down 32.26% YoY) and the FY2025 annual result came in at $5.2 million, changed N/A from the prior year.
- Other Non-Current Liabilities was $1.3 million for Q1 2026 at Femasys, down from $5.2 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $6.7 million in Q3 2025 and bottomed at $567972.0 in Q2 2022.
- A 5-year average of $2.1 million and a median of $1.8 million in 2025 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2023 — Other Non-Current Liabilities soared 390.72% — and 2026, when it plunged 32.26%.
- Femasys' Other Non-Current Liabilities stood at $567972.0 in 2022, then surged by 390.72% to $2.8 million in 2023, then decreased by 6.4% to $2.6 million in 2024, then soared by 101.11% to $5.2 million in 2025, then slumped by 75.98% to $1.3 million in 2026.
- Business Quant data shows FEMY's Other Non-Current Liabilities at $1.3 million in Q1 2026, $5.2 million in Q4 2025, and $6.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn |
| 10 | Femasys | 17.46 Mn | 12.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 5.25 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 1.82 Mn |
| Mar 31, 2025 | 1.86 Mn |
| Sep 30, 2024 | 2.61 Mn |
| Jun 30, 2024 | 2.61 Mn |
| Mar 31, 2024 | 2.63 Mn |
| Dec 31, 2023 | 2.79 Mn |
| Sep 30, 2023 | 1.58 Mn |
| Jun 30, 2023 | 1.92 Mn |
| Mar 31, 2023 | 567,972.00 |
| Dec 31, 2022 | 567,972.00 |
| Sep 30, 2022 | 567,972.00 |
| Jun 30, 2022 | 567,972.00 |
| Mar 31, 2022 | 702,492.00 |
| Dec 31, 2021 | 702,492.00 |
| Sep 30, 2021 | 702,492.00 |
| Jun 30, 2021 | 702,492.00 |
| Dec 31, 2020 | 32,895.00 |